IndraLab

Statements

Pirarubicin decreases the amount of USP22. 1 / 1

| 1

reach

"Recently, Pirarubicin (4’-O-tetrahydropyranyl doxorubicin, THP), an anthracycline (analogue of another chemotherapeutic agent known as doxorubicin), has been shown to inhibit USP22 expression in a condition-specific manner ."

34660907

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Pirarubicin decreases the amount of USP22. 1 / 1

INDRA sources:

Databases

Reading